Sanofi Pasteur announces FDA approval of Menactra® - European  Pharmaceutical Review

Sanofi Pasteur announces FDA approval of Menactra® - European Pharmaceutical Review

4.8
(602)
Écrire un avis
Plus
€ 14.50
Ajouter au panier
En Stock
Description

Immunization Update - Advances in Pediatrics

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

Sanofi Access to Medicine Foundation

Menactra Vaccine, Sanofi Pasteur at best price in Mumbai

Sanofi - Wikipedia

Haemophilus Influenzae Type B Meningococcus Tetanus Vaccine - an overview

2019/12 – IR – Capital Markets Day

Full article: Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence

The status of COVID-19 vaccines in India: A review

Meningococcal Meningitis (MenACWY) Vaccine MenQuadfi® (Meningococcal [Groups A, C, Y, W] Conjugate Vaccine)

PDF) Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT, Nimenrix™): A review of its Immunogenicity, Safety, Co-Administration, and Antibody Persistence

Menactra Meningococcal Diphtheria Toxoid Conjugate Vaccine, Sanofi Pasteur at Rs 3600/piece in Jalandhar

Sanofi Pasteur 589-05 - McKesson Medical-Surgical